Edward W. Withrow III - 31 Dec 2021 Form 5 Insider Report for PARALLAX HEALTH SCIENCES, INC.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
5
Accepted by SEC
17 Mar 2022, 17:15:39 UTC
Prior SEC filing
04 Mar 2022
Next SEC filing
17 Mar 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
EDWARD W. WITHROW III

Key filing fact

Edward W. Withrow III filed Form 5 for PARALLAX HEALTH SCIENCES, INC. on 17 Mar 2022.

Key facts

  • This page summarizes Edward W. Withrow III's Form 5 filing for PARALLAX HEALTH SCIENCES, INC..
  • 5 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 17 Mar 2022, 17:15.

Change

  • Previous filing in this sequence was filed on 04 Mar 2022.
  • Current net transaction value: +$99,932.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 5 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRLX transaction

PREFERRED STOCK (SERIES A)

Other

Transaction value
$99,932
Shares
+36,339
Change %
+10%
Price
$2.75
Shares after
399,732
Date
30 Sep 2011
Ownership
By Huntington Chase Financial Group
Footnotes
F1
PRLX transaction

PREFERRED STOCK (SERIES A)

Other

Transaction value
$0
Shares
+396,339
Change %
+99%
Price
$0.000000
Shares after
796,071
Date
06 Nov 2021
Ownership
By Huntington Chase Financial Group
Footnotes
F2
PRLX transaction

PREFERRED STOCK (SERIES A)

Other

Transaction value
$0
Shares
-796,071
Change %
-100%
Price
$0.000000*
Shares after
0
Date
06 Nov 2021
Ownership
By Huntington Chase Financial Group
Footnotes
F3
PRLX transaction

COMMON STOCK

Other

Transaction value
$0
Shares
+15,921,420
Change %
+28%
Price
$0.000000
Shares after
72,430,792
Date
06 Nov 2021
Ownership
By Huntington Chase LLC
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PRLX transaction Derivative

STOCK OPTION

Disposed to Issuer

Transaction value
$0
Shares
-3,000,000
Change %
-75%
Price
$0.000000
Shares after
1,000,000
Date
31 Mar 2021
Ownership
By Huntington Chase LLC
Underlying class
COMMON STOCK
Underlying amount
3,000,000
Exercise price
$0.2500
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Additional Series A Preferred shares acquired; not included in previous Form 5 for the year 12/31/2012. Total Series A Preferred shares held at 12/31/12 = 399,732.

Footnote F2

Cumulative dividends in kind on Series A Preferred Stock.

Footnote F3

Conversion of preferred stock into common stock at a ratio of 20 shares of common stock for each share of preferred stock.

Footnote F4

Unvested stock options canceled upon resignation of Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .